234 related articles for article (PubMed ID: 32827351)
1. Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease.
Liu CC; Yamazaki Y; Heckman MG; Martens YA; Jia L; Yamazaki A; Diehl NN; Zhao J; Zhao N; DeTure M; Davis MD; Felton LM; Qiao W; Li Y; Li H; Fu Y; Wang N; Wren M; Aikawa T; Holm ML; Oue H; Linares C; Allen M; Carrasquillo MM; Murray ME; Petersen RC; Ertekin-Taner N; Dickson DW; Kanekiyo T; Bu G
Alzheimers Dement; 2020 Oct; 16(10):1372-1383. PubMed ID: 32827351
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.
Yamazaki Y; Shinohara M; Shinohara M; Yamazaki A; Murray ME; Liesinger AM; Heckman MG; Lesser ER; Parisi JE; Petersen RC; Dickson DW; Kanekiyo T; Bu G
Brain; 2019 Apr; 142(4):1077-1092. PubMed ID: 30770921
[TBL] [Abstract][Full Text] [Related]
3. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
4. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
5. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
van Helmond Z; Miners JS; Kehoe PG; Love S
Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
[TBL] [Abstract][Full Text] [Related]
6. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
7. Endothelial BACE1 Impairs Cerebral Small Vessels via Tight Junctions and eNOS.
Zhou H; Gao F; Yang X; Lin T; Li Z; Wang Q; Yao Y; Li L; Ding X; Shi K; Liu Q; Bao H; Long Z; Wu Z; Vassar R; Cheng X; Li R; Shen Y
Circ Res; 2022 Apr; 130(9):1321-1341. PubMed ID: 35382554
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
9. Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease.
Raulin AC; Doss SV; Heckman MG; Craver EC; Li Z; Ikezu TC; Sekiya H; Liu CC; Martens YA; Rosenberg CL; Kuchenbecker LA; DeTure M; Reichard RR; Nguyen AT; Constantopoulos E; Larsen RA; Kounaves EK; Murray ME; Dickson DW; Petersen RC; Bu G; Kanekiyo T
Acta Neuropathol Commun; 2024 Feb; 12(1):25. PubMed ID: 38336940
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
11. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
Merlini M; Wanner D; Nitsch RM
Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
[TBL] [Abstract][Full Text] [Related]
12. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.
Soontornniyomkij V; Moore DJ; Gouaux B; Soontornniyomkij B; Tatro ET; Umlauf A; Masliah E; Levine AJ; Singer EJ; Vinters HV; Gelman BB; Morgello S; Cherner M; Grant I; Achim CL
AIDS; 2012 Nov; 26(18):2327-35. PubMed ID: 23018443
[TBL] [Abstract][Full Text] [Related]
13. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
[TBL] [Abstract][Full Text] [Related]
14. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
16. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.
Kövari E; Herrmann FR; Hof PR; Bouras C
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):498-509. PubMed ID: 23163235
[TBL] [Abstract][Full Text] [Related]
17. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
19. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
McAleese KE; Graham S; Dey M; Walker L; Erskine D; Johnson M; Johnston E; Thomas AJ; McKeith IG; DeCarli C; Attems J
Brain Pathol; 2019 May; 29(3):414-424. PubMed ID: 30485582
[TBL] [Abstract][Full Text] [Related]
20. Retinal arterial Aβ
Shi H; Koronyo Y; Fuchs DT; Sheyn J; Jallow O; Mandalia K; Graham SL; Gupta VK; Mirzaei M; Kramerov AA; Ljubimov AV; Hawes D; Miller CA; Black KL; Carare RO; Koronyo-Hamaoui M
Alzheimers Dement; 2023 Nov; 19(11):5185-5197. PubMed ID: 37166032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
